S
Sang Il Kim
Researcher at Catholic University of Korea
Publications - 172
Citations - 2330
Sang Il Kim is an academic researcher from Catholic University of Korea. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 21, co-authored 147 publications receiving 1788 citations. Previous affiliations of Sang Il Kim include Kyungpook National University & St Mary's Hospital.
Papers
More filters
Journal ArticleDOI
High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia.
Doo Ryeon Chung,Jae-Hoon Song,So Hyun Kim,Visanu Thamlikitkul,Shao-Guang Huang,Hui Wang,Hui Wang,Thomas Man-kit So,Rohani Md Yasin,Po-Ren Hsueh,Celia C. Carlos,Li Yang Hsu,Latre Buntaran,M. K. Lalitha,Min Ja Kim,Jun Yong Choi,Sang Il Kim,Kwan Soo Ko,Cheol-In Kang,Kyong Ran Peck +19 more
TL;DR: These isolates are highly resistant to major antimicrobial agents, which could limit the therapeutic options in the clinical practice and significantly increases the likelihood of pneumonia-related mortality.
Journal ArticleDOI
Spinal Cord Injury and Related Clinical Trials.
TL;DR: The pathophysiology of SCI is discussed, the therapeutic candidates that have been developed so far are introduced and the aims of neuroprotective and neuroregenerative treatment are explained.
Journal ArticleDOI
Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy
Youn Jeong Kim,Yoon Hee Jun,Yang Ree Kim,Kang Gyun Park,Yeon Joon Park,Ji Young Kang,Sang Il Kim +6 more
TL;DR: Disease severity was a critical factor for mortality in patients with P. aeruginosa bacteremia and combination therapy had no significant effect on 14-day mortality compared with monotherapy, however, appropriate combination therapy showed a favorable effect on survival in Patients with febrile neutropenia.
Journal ArticleDOI
Risk factors for mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: impact of appropriate antimicrobial therapy.
TL;DR: Early definite antimicrobial therapy had an influence on favorable outcomes in patients with A. baumannii bacteremia as well as other predictors associated with 14-day mortality.
Journal ArticleDOI
Infectious complications in living‐donor liver transplant recipients: a 9‐year single‐center experience
Youn Jeong Kim,Sang Il Kim,Seong-Heon Wie,Yeon-Sil Kim,J.A. Hur,Jong Young Choi,Sungjoo Kim Yoon,In-Sung Moon,Dong Goo Kim,M.D. Lee,Moo-Il Kang +10 more
TL;DR: The frequency and type of infectious complications according to the post‐transplantation period, and their risk factors with regard to morbidity and mortality, are analyzed.